CAR inhibited the proliferation and metastasis of non-small cell lung cancer A549 and H460 cells by reducing the phosphorylation level of the downstream effector phosphoinositide 3 kinase (PI3K) 19. The gene discussed is PIK3CD; the disease is non-small cell lung carcinoma.